{
    "Allele Frequency": "0.084", 
    "Build 37 Chromosome": "chr8", 
    "Build 37 Position": "19819724", 
    "Build 37 Variant Allele": "G", 
    "Build37 coordinates:": [], 
    "Clinical Importance": "Low", 
    "Condition Tags": [
        "Metabolism"
    ], 
    "Evidence": "Uncertain", 
    "Gene Symbol": "LPL", 
    "Impact": "Protective", 
    "Inheritance": "Unknown", 
    "PMID Count": 6, 
    "PMID List": [
        "16574898", 
        "17463246", 
        "18193044", 
        "19802338", 
        "20429872", 
        "22042884"
    ], 
    "Scores": {
        "Case/Control": "1", 
        "Computational": "2", 
        "Familial": null, 
        "Functional": "1", 
        "Penetrance": null, 
        "Severity": "1", 
        "Treatability": "0"
    }, 
    "Summary": "This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.", 
    "URL": "http://evidence.pgp-hms.org/LPL-S474X", 
    "Variant Name": "LPL-S474X", 
    "Variant Page": "http://evidence.pgp-hms.org/LPL-S474X", 
    "dbSNP IDs": [
        "rs328"
    ]
}